These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2563242)

  • 21. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
    Michalkiewicz M; Suzuki M; Kato M
    Endocrinology; 1987 Jul; 121(1):371-7. PubMed ID: 2885177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatostatin release from dispersed hypothalamic cells - effects of membrane depolarization, calcium and glucose deprivation.
    Richardson SB; Greenleaf P; Hollander CS
    Brain Res; 1983 Apr; 266(1):75-81. PubMed ID: 6133593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-1 beta modulates the acute release of growth hormone-releasing hormone and somatostatin from rat hypothalamus in vitro, whereas tumor necrosis factor and interleukin-6 have no effect.
    Honegger J; Spagnoli A; D'Urso R; Navarra P; Tsagarakis S; Besser GM; Grossman AB
    Endocrinology; 1991 Sep; 129(3):1275-82. PubMed ID: 1678697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose modulation of somatostatin and LHRH release from rat hypothalamic fragments in vitro.
    Lengyel AM; Grossman A; Nieuwenhuyzen-Kruseman AC; Ackland J; Rees LH; Besser M
    Neuroendocrinology; 1984 Jul; 39(1):31-8. PubMed ID: 6146938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse hypothalamic somatostatin release: roles of calcium and calmodulin.
    Richardson S; Twente S
    Endocrinology; 1985 Jul; 117(1):369-75. PubMed ID: 2861080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of alterations in the pituitary-thyroid axis on hypothalamic content and in vitro release of somatostatin-like immunoreactivity.
    Berelowitz M; Maeda K; Harris S; Frohman LA
    Endocrinology; 1980 Jul; 107(1):24-9. PubMed ID: 6103803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired suppression of growth hormone release by somatostatin in cultured adenohypophyseal cells of spontaneously diabetic BB/W rats.
    Welsh JB; Szabo M
    Endocrinology; 1988 Nov; 123(5):2230-4. PubMed ID: 2901949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of rat growth hormone (rGH)-releasing factor and somatostatin on the release and synthesis of rGH in dispersed pituitary cells.
    Fukata J; Diamond DJ; Martin JB
    Endocrinology; 1985 Aug; 117(2):457-67. PubMed ID: 2862007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus.
    Tannenbaum GS; McCarthy GF; Zeitler P; Beaudet A
    Endocrinology; 1990 Nov; 127(5):2551-60. PubMed ID: 1977581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calmodulin dependence of somatostatin release stimulated by growth hormone-releasing factor.
    Aguila MC; McCann SM
    Endocrinology; 1988 Jul; 123(1):305-9. PubMed ID: 2898360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of glucagon, Neurotensin, and vasoactive intestinal polypeptide on somatostatin release from perifused rat hypothalamus.
    Shimatsu A; Kato Y; Matsushita N; Katakami H; Yanaihara N; Imura H
    Endocrinology; 1982 Jun; 110(6):2113-7. PubMed ID: 6122561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of diabetes on in vivo and in vitro hypothalamic somatostatin release.
    Joanny P; Peyre G; Steinberg J; Guillaume V; Pesce G; Becquet D; Oliver C
    Neuroendocrinology; 1992 May; 55(5):485-91. PubMed ID: 1350065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of age on somatostatin suppression of basal, growth hormone (GH)-releasing factor-stimulated, and dibutyryl adenosine 3',5'-monophosphate-stimulated GH release from rat pituitary cells in monolayer culture.
    Cuttler L; Welsh JB; Szabo M
    Endocrinology; 1986 Jul; 119(1):152-8. PubMed ID: 2873023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interrelation between somatostatin output from the mediobasal hypothalamus and plasma growth hormone levels in conscious rats: effects of glucagon administration.
    Katakami H; Kato Y; Matsushita N; Shimatsu A; Waseda N; Imura H
    Endocrinology; 1984 Oct; 115(4):1598-604. PubMed ID: 6148235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatostatin inhibition of pancreatic glucagon release from monolayer cultures and interactions with calcium.
    Wollheim CB; Blondel B; Renold AE; Sharp GW
    Endocrinology; 1977 Sep; 101(3):911-9. PubMed ID: 330154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine stimulates somatostatin release from perifused hypothalamic cells.
    Richardson SB; Nguyen T; Hollander CS
    Am J Physiol; 1983 Jun; 244(6):E560-6. PubMed ID: 6134472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endotoxin-induced release of interleukin-6 from rat medial basal hypothalami.
    Spangelo BL; Judd AM; MacLeod RM; Goodman DW; Isakson PC
    Endocrinology; 1990 Oct; 127(4):1779-85. PubMed ID: 1976093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant increases in serum growth hormone and hypothalamic somatostatin in rats after injection of gamma-aminobutyric acid, aminooxyacetic acid, or gamma-hydroxybutyric acid.
    Takahara J; Yunoki S; Hosogi H; Yakushiji W; Kageyama J; Ofuji T
    Endocrinology; 1980 Jan; 106(1):343-7. PubMed ID: 7349964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 17 beta-estradiol induces somatostatin (SRIF) inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells.
    Kimura N; Hayafuji C; Konagaya H; Takahashi K
    Endocrinology; 1986 Sep; 119(3):1028-36. PubMed ID: 2874016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the hypophysis in regulation of pancreatic and gastric somatostatin.
    Recant L; Voyles NR; Wilkins SD; Fairtile RD; King C
    Endocrinology; 1984 Dec; 115(6):2260-5. PubMed ID: 6149930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.